Bio-Rad’s Chief Operating Officer Andrew Last to Retire
10 Aprile 2024 - 10:15PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global
leader in life science research and clinical diagnostics products,
today announced that Dr. Andrew Last, Executive Vice President and
Chief Operating Officer, is planning to retire by early September
of 2024. Dr. Last will remain part of Bio-Rad’s executive
leadership team to ensure a smooth transition while the company
conducts a search for his successor.
Dr. Last joined Bio-Rad in April of 2019 with over 30 years of
experience in global operations management spanning the life
sciences.
“Andy’s extensive operations experience, technical acumen, and
leadership abilities have been invaluable to Bio-Rad over the past
five years,” said Norman Schwartz, Bio-Rad President and CEO. “We
have made significant progress on our transformational objectives,
including cost structure, core processes, and supply chain
improvements, while effectively navigating various macroeconomic
challenges.”
Dr. Last stated, “When I reflect on my tenure at Bio-Rad, I am
most proud of the team we have built and the operations and
management systems we have put in place. I am confident that these
accomplishments have positioned Bio-Rad well for the next phase of
its continued journey of transformation and growth.”
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in
developing, manufacturing, and marketing a broad range of products
for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of
research, development, manufacturing, and sales operations with
over 8,000 employees and $2.7 billion in revenues in 2023. Our
customers include universities, research institutions, hospitals,
food safety and environmental quality laboratories, and
biopharmaceutical companies. Together, we develop innovative,
high-quality products that advance science and save lives. To learn
more, visit bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240410118260/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 cc@bio-rad.com
Grafico Azioni Bio Rad Laboratories (NYSE:BIO)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Bio Rad Laboratories (NYSE:BIO)
Storico
Da Nov 2023 a Nov 2024
